Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES. DIMETHYL FUMARATE delayed-release capsules, for oral use Initial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-prescription
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
- generic_name
- dimethyl fumarate
- product_names
- Dimethyl fumarate, Dimethyl Fumarate
- ndc
- 69539-042, 69539-043, 69539-240, 69539-042-61, 69539-042-05, 69539-043-60, 69539-043-05, 69539-240-18
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en